We are live on
!
Find out more
CMMB
Chemomab Therapeutics
CMMB
CMMB
14 hedge funds and large institutions have $4.91M invested in Chemomab Therapeutics in 2025 Q2 according to their latest regulatory filings, with 2 funds opening new positions, 5 increasing their positions, 3 reducing their positions, and 5 closing their positions.
New
Increased
Maintained
Reduced
Closed
67% more repeat investments, than reductions
Existing positions increased: 5 | Existing positions reduced: 3
21% more capital invested
Capital invested by funds: $4.07M → $4.91M (+$840K)
5.36% more ownership
Funds ownership: 0.25% → 5.61% (+5.4%)
18% less funds holding
Funds holding: 17 → 14 (-3)
60% less first-time investments, than exits
New positions opened: 2 | Existing positions closed: 5
Holders
14
Holders Change
-3
Holders Change %
-17.65%
% of All Funds
0.18%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
2
Increased
5
Reduced
3
Closed
5
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
Morgan Stanley
New York
|
+$1.85M |
| 2 |
Jane Street
New York
|
+$25.4K |
| 3 |
RhumbLine Advisers
Boston,
Massachusetts
|
+$19.8K |
| 4 |
BNP Paribas Financial Markets
Paris,
France
|
+$4.21K |
| 5 |
GI
GAMMA Investing
Foster City,
California
|
+$2.21K |
Top Sellers
| 1 |
O
OrbiMed
New York
|
-$990K |
| 2 |
SFM
Sphera Funds Management
Tel Aviv,
Israel
|
-$201K |
| 3 |
VF
Virtu Financial
New York
|
-$34K |
| 4 |
TSS
Two Sigma Securities
New York
|
-$24.1K |
| 5 |
XT
XTX Topco
George Town,
Cayman Islands
|
-$14.5K |
